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General Subcellular Effects of
Lead, Mercury, Cadmium, and Arsenic
by Bruce A. Fowler*
This working paper summarizes the known ultrastructural and biochemical effects of lead, mercury,
cadmium, and arsenic on subcellular organeUle systems following in vivo administration. Documented
metal-induced alterations in nuclear, mitochondrial, microsomal, and lysosomal functions are discussed
in relation totheir potential impact oncellular responsestootherenvironmental agents. Each ofthe above
elements has been found to interfere with normal cellular replication and genetic processes. Mitochon-
drial swelling and depression of respiratory function are discussed in relation to known metal-specific
perturbations of mitochondrial heme biosynthetic pathway enzymes. Inhibition of microsomal enzyme
activities and protein synthesis by lead and mercury is compared to the apparent absence ofsuch effects
following arsenic or cadmium exposure. Lysosomal uptake ofall the metals is documented, but biochemi-
cal alterations in these structures have been reported for only mercury and cadmium. It is concluded that
these toxic metals are capable of interacting with, and biochemicaly altering major cellular systems at
dose levels below those required to produce signs of overt metal toxicity. The impact ofthese effects on
cellular responses to other metals and xenobiotics in complex exposure situations is presently unknown,
and further research is urgentiy needed in this area.
Introduction
Toxic trace metals like lead, mercury, cadmium,
and arsenic are present in some fossil fuels and may
be emitted in substantial quantities during the
course of energy production. Release of these ele-
ments into the environment from power plants may
lead to their accumulation in soil, water and edible
biota at appreciable distances from the original
source. Ingestion ofpica, water, or food organisms
such as fish contaminated with these elements rep-
resents a potential human health hazard of un-
known magnitude. The problem ofassessing biolog-
ical effects in humans after prolonged low-level ex-
posure to these elements is complicated by a basic
lack of understanding concerning the in vivo
mechanisms of metal toxicity and the impact of
trace element exposure on cellular responses to
other environmental toxicants such as carcinogens.
It is presently clear, however, that many cellular
systems affected by trace elements are also sensi-
tive to other classes of toxicants.
The following discussion will attempt to sum-
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marize current knowledge ofhow important subcel-
lular organelle systems respond to prolonged lead,
mercury, cadmium and arsenic exposure. It is
hoped that this information will provide a basis for
discussing possible interactive effects between
metals and other environmental agents released
during energy production.
Lead
The effects of lead on subcellular systems have
been extensively reviewed by Goyer and Rhyne
(1, 2). It is clear from these reviews that lead is a
broad-spectrum agent which may exert pronounced
effects on a numberofcellular systems. Thefollow-
ing discussion will focus on some of the more sa-
lient general effects of lead utilizing an organelle
system basis.
Nuclei (Genetic and Chromosomal Effects)
The most prominent early cellular manifestation
of prolonged lead exposure is the formation of in-
tranuclear inclusion bodies which are most
prominent in the kidney (3). These structures which
are formed early in the course of lead exposure
(1,3) are thought to represent a major intracellular
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exposure of other subcellular systems to this ele-
ment (1). It is worth noting that nuclear exposure to
lead may also lead to karyomegaly (1), polyploidy,
and abnormal mitoses (4). Muro and Goyer (5)
have reported a 13-fold greater incidence of
chromosomal gaps in cultured bone marrow cells
from mice fed adiet containing 1%lead acetate for2
weeks in comparison with controls. These authors
also noted a5.4% greaterincidence ofchromosomal
breaks and a 12% greater incidence ofchromosome
fragments in these cells.
A single low injected dose oflead (5 ,ug/g) has also
been found (6) temporarily to stimulate synthesis of
new DNA in mouse kidney by a factor of45 times.
This phenomenon was preceded by a general in-
crease in synthesis of new RNA and protein (7). It
is clear from these studies that lead may interact
with cell nuclei in vivo and is capable ofproducing
both morphological and functional alteration of nu-
clear processes in target organ systems.
Mitochondria
The effects oflead on these organelles which are
essential to cellular energy production, carbohy-
drate metabolism, and heme biosynthesis have been
extensively studied. Mitochondrial accumulation of
lead in the kidney, and the resultant swelling, are
early signs of nephrotoxicity from this element (1).
Biochemical studies of lead-poisoned mitochondria
(2) have shown NAD-linked substrate mediated
respiration in animals fed a 1% lead dietfor 10weeks
to be more strongly inhibited than that supported by
succinate. Decreases of approximately 23% for
mitochondrial control ratios and 23% for P/O ratios
were observed. The substrate specificity of this
phenomenon is thought to occurvialead inhibition of
the lipoic acid dehydrogenase complex. Lead has
also been found to inhibit the mitochondrial heme
biosynthetic enzymes 8-aminolevulinic acid (ALA)
synthetase and ferrochelatase (1) which may in part
account for depression ofmitochondrial cytochrome
aa3 content in lead-poisoned mitochondria (8). The
important effects oflead on this organelle system are
that it may cause cell death by impairment ofenergy
production and compromise cellular detoxification
capabilities via inhibition of intracellular hemopro-
tein function with resultant excretion of copropor-
phyrin.
Endoplasmic Reticulum (Microsomal
Enzyme Activities and Protein Synthesis)
Administration of lead at an injected dose of 5
mg/kg has been found to inhibit the activities of rat
hepatic microsomal drug metabolizing enzymes by
about 50o and to decrease cytochrome P450 con-
tent by about 40% (9). The exact biochemical
mechanisms for this effect are unknown, but lead
inhibition of cellular heme biosynthesis (1) and dis-
aggregation ofpolyribosomes (10) are both potential
explanations.
Lysosomes
Studies by Baltrop et al. (11) have indicated that
some lead is concentrated in lysosomes following
prolonged exposure. It is unclear whether this effect
occurs as a primary mechanism for metal sequestra-
tion or whether it is secondary to autophagy oflead-
poisoned organelles such as mitochondria.
Mercury
Mercury is apotent cellularpoison whose mode of
action and target organ systems are somewhat de-
pendent upon the chemical form of mercury in-
volved. Methylmercury is the mercurial of greatest
general environmental concern and hence the follow-
ing discussion will focus on available data concern-
ing the subcellular effects ofthis agent.
Nuclei (Genetic and Chromosomal)
Brubaker et al. (12) have studied the effects of
methylmercury on DNA, RNA, and protein syn-
thesis in several organ systems following subacute
exposure to injected doses of 10 mg/kg. These au-
thors observed generally greater synthesis ofDNA,
RNA, and protein in the livers of treated animals.
DNA synthesis increased about 45% at low tissue
levels of mercury; however, at higher levels of tis-
sue mercury, DNA synthesis returned to control
levels while both protein and RNA synthesis were
increased about 77 and 83%, respectively. Similar
increases were noted in the brains ofthese animals.
In contrast, renal DNA and protein synthesis were
decreased by 36 and 28%, respectively, while RNA
synthesis was elevated by about 20%o. The authors
concluded that, in general, in vivo methylmercury
treatment did not appear to impair normal nuclear
DNA or RNA synthetic processes markedly.
Mitochondria
Prolonged exposure to methylmercury has been
found to produce in situ mitochondrial damage in
both liver and kidneys (13-17). These morphological
changes are associated with moderate changes in
mitochondrial respiratory function and marker en-
zyme activities (17, 18). Hepatic mitochondria from
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mercury at daily dose levels of 0.42, 0.7, and 1.4
mg/kg for 6 weeks were found to show decreases of
21, 45 and 61%, respectively, in protein synthesis.
This effect was associated with decreases ofapprox-
imately 20-30% in the specific activities of the
mitochondrial marker enzymes monoamine ox-
idase, cytochrome oxidase, and ALA synthetase.
Adult renal mitochondria from animals exposed to
the same regimen showed a different response pat-
tern (18). The most pronounced effect ofmethylmer-
cury on renal mitochondria appears to entail the
selective involvement ofmitochondrialheme biosyn-
thesis, leading to a 2.5-fold increase in ALA syn-
thetase and decrease of ferrochelatase to 70%o of
control values. These enzymatic perturbations re-
sult in a porphyrin excretion pattern characterized
by an approximately 21-fold increase in urinary
coproporphyrin which occurs prior to the onset of
overt toxicity (18). In summary, the effects of
methylmercury on this organelle system may cause
cell death and a decrease in intracellular hemopro-
tein synthesis.
Lysosomes
Mercury derived from methylmercury exposure
has been found to accumulate in lysosomes ofboth
liver (19) and kidney (14), where at dose levels of
0.42, 0.7, or 1.4 mg/kg/day it decreased the activities
of /3-glucuronidase by approximately 55% and in-
creased the specific activity of acid phosphatase by
80-100o (15). The potentialbiological significance of
this effect rests with the fact that lysosomes are also
known to accumulate and sequester other foreign
compounds such as drugs and dyes (20). Perturba-
tion of this system by mercury could presumably
alterthis cellular defense system in ways which have
not been investigated.
Endoplasmic Reticulum (Microsomal
Enzyme Activities and Protein Synthesis)
Administration ofmethylmercury to experimental
animals has been found to reduce the activities of
hepatic microsomal enzyme systems and cyto-
cnrome P-450 content by approximately 50o follow-
ing injected doses of 5 or 10 mg/kg (21-23). Activity
of hepatic glucuronyl transferase has been found to
be unaffected in these studies (23). Methylmercury
effects on microsomal drug-metabolizing capability
may be attributable to an approximately 2-fold en-
hancement of CO-binding component degradation
(22) and/or decrease in protein synthesis at the 10
mg/kg dose level (12).
Cadmium
Cadmium is another important toxic metal whose
in vivo metabolism and cellular mechanisms of tox-
icity appear to be highly complex.
Nuclei (Genetic and Chromosomal)
The known genetic effects of cadmium have been
recently well summarized (24). Studies on humans
have shown a higher incidence of chromosome ab-
normalities (about 50-60%) in human populations
with known exposure to this element. Data from
animal studies have also shown that cadmium can
cause malignant tumors at the site of injection. The
exact biochemical mechanisms behind these effects
and factors which influence the toxic processes are
unknown and await further study.
Mitochondria
In vitro studies with Cd+2 have shown that this
ion becomes strongly bound to mitochondria (25)
and is capable ofinhibiting respiration (by 75%) and
oxidative phosphorylation (by 100%) at concen-
trations as low as 5 x 10-6M (25, 26). Complete
inhibition of 1-hydroxylation of vitamin D by renal
mitochondria at a concentration of 0.025mM has
also been observed (27). Whether these mitochon-
drial effects of cadmium occur in vivo is probably
dependent upon the synthesis, availability and deg-
radation of cadmium metallothionein (27). The ef-
fects of cadmium on other mitochondrial functions
have not been studied.
Endoplasmic Reticulum (Microsomal
Enzyme Activities and Protein Synthesis)
Cadmium administration is known to result in the
synthesis of metallothionein (28). This protein ap-
pears to play an important role in mediating the in
vivo metabolism and toxicity of cadmium. The
exact mechanisms by which cadmium induces this
protein are presently unknown and the effects of
cadmium metallothionein synthesis on normal cellu-
larprotein synthesis and drug metabolizing function
are also unclear.
Lysosomes
Cadmium ions have been found in vivo to inhibit
normal heterolysosome proteolysis in mice by
about 40 percent after a dose of 4.3 mg/kg (29).
Recent in vivo studies (30, 31) have shown that the
lysosome system may also play an important role in
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metallothionein. The impact of cadmium metal-
lothionein on renal lysosome function under chronic
exposure conditions remains unknown.
Arsenic
In discussing the subcellular effects of arsenic, it
is important to distinguish both chemical form and
oxidation state. In general, especially for inorganic
arsenic, the trivalent (arsenite) form is considered
to be ofgreatest concern, although the pentavalent
(arsenate) is the more common environmental form.
Nuclei (Genetic and Chromosomal)
Arsenicals have been reported in vitro to inter-
fere with normal DNA repair(32-34). Epidemiolog-
ical studies have also shown an approximate 5-fold
higher incidence of lymphocyte chromosome
anomalies (35) and 3-fold greater lung cancer inci-
dence (36) among smelter workers in high arsenical
exposure situations. Animal studies dealing with
the carcinogenic effects of arsenic have proven in-
conclusive to date.
Mitochondria
Arsenicals are known selectively to inhibit
NAD-linked mitochondrial respiration and to un-
couple oxidative phosphorylation. Konings (37)
found an approximately 80% decrease in NAD-
linked respiration of liver mitochondria incubated
with arsenite at a concentration of 0.ImM. Similar
in vivo findings have been recently reported (38) in
rodents following oral exposure to arsenate at doses
of 1.2, 2.2, and 3.5 mg/kgfor6 weeks. Mitochondria
from these animals also showed 50-70% increases
in the specific activities ofthe mitochondrial marker
enzymes monoamine oxidase, cytochrome oxidase
and Mg+2ATPase. Another effect involved per-
turbation ofmitochondrial hemebiosynthesis with a
resulting porphyrinuria (39) which is distinct from
that observed with methylmercury or lead. A max-
imal decrease ofheme synthetase activity to 63% of
control levels was observed at the 3.5 mg/kg dose
level with a resultant increase in urinary uropor-
phyrin and a lesser increase in coproporphyrin.
Endoplasmic Reticulum. (Microsomal
Enzyme Activities and Protein Synthesis)
The effects of arsenic microsomal enzyme ac-
tivities have received relatively little attention but
recent studies from our laboratories (39) seem to
indicate little change in microsomal enzyme ac-
tivities or cytochrome P-450 content following pro-
longed oral exposure. A general increase in liver
microsomal protein synthesis was also observed in
these animals as an apparent sequelae to cell death
and replacement.
Lysosomes
Increased numbers of electron dense autophagic
lysosomes have been noted (40) in renal proximal
tubule cells of arsenate-treated rats. Replicate
studies (41) have failed to demonstrate any signifi-
cant changes in the activities oflysosomal enzymes.
Summary
It should be clear from the above discussion that
toxic metals are capable of interacting with, and
biologically altering, major cellular systems at dose
levels below those required to produce signs of
overt metal toxicity. The impact ofthese effects on
cellular responses to other metals and xenobiotics
in complex exposure situations is presently unclear
and further research is urgently needed in this area.
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